Contraception and endometriosis treatments added to PBS ‘Good news all round’: GPs have welcomed new and amended PBS listings for Slinda, Ryeqo and Pergoveris, which will come into place over the next six weeks.
In Practice: Be prepared for 2025 flu season With flu season approaching, ATAGI is reminding GPs to keep up to date with the latest vaccine advice and resources.
‘Breakthrough’ blood test for endometriosis: Study A new and non-invasive way to test early for the often-debilitating condition has been developed by Australian researchers.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
New link between endometriosis and ovarian cancer The study found women with deep infiltrating endometriosis have a tenfold increase in risk for the cancer, but one GP expert has urged caution.
GPs urged to ask about period pain early A 20-year study has found one third of 14-year-old girls have serious menstrual pain, but early advice could save them years of suffering.
Longer consults for endometriosis sufferers on the way A $49 million funding boost will see two new MBS items added in July next year for specialist gynaecological appointments.
What is Ryeqo? While the medicine has already been available in Australia since 2022, it was recently approved for the treatment of endometriosis.
‘Pregnancy cures endometriosis’ myth persists More than half of all women in a new study said they were advised to have a baby to treat their symptoms, labelling it ‘a nightmare’.
Endometriosis hospitalisation twice as likely to be self-funded: AIHW The condition is also now among the top 20 most common reasons for hospitalisation among women and girls aged 15–44.